Vaccines is the only place in Pfizer where you can contribute to patients in a way like no other – you can prevent sickness and disease. This is at the heart of what drive us every day and it brings us great #Joy. This role will be accountable to shape and drive the strategy for providing protection against Lyme disease in the US. Lyme disease is a systemic infection caused by Borrelia burgdorferi bacteria transmitted to humans by the bite of infected Ixodes ticks. It is considered the most common vector-borne illness in the Northern Hemisphere. Early symptoms of Lyme disease (such as a gradually expanding erythematous rash called erythema migrans or other nonspecific symptoms like fatigue, fever, headache, mild stiff neck, muscle and joint pains) are often overlooked or misinterpreted. Left untreated, the disease can disseminate and cause more serious chronic complications affecting the skin, joints (arthritis), heart (carditis) or nervous system. Preventive measures for Lyme disease are limited by their effectiveness and compliance (e.g., insect repellent, removing ticks promptly and reducing tick habitat) and no vaccine is currently available. The medical need for vaccination against Lyme disease is steadily increasing as the geographic footprint of the disease widens. LB6V (formerly known as VLA-15) is currently undergoing Phase 3 development for the prevention of Lyme Disease in individuals 5 years of age and older. With expected FDA approval in 1H 2027, a US marketing team for LB6V is being formed to advance key pre-launch workstreams. The U.S. Lyme vaccine is an investigational vaccine currently in development, with the goal of launching in the United States in 2027. This vaccine aims to address the growing public health challenge posed by Lyme disease by providing a preventive solution for individuals at risk. The launch team plays a critical role in shaping strategy, education, and engagement to ensure successful introduction and adoption upon approval. Role Purpose Lead the comprehensive launch readiness and field enablement strategy for the Customer-Facing Colleague (CFC) team to ensure optimal execution of marketing strategies and tactical plans. This role focuses on driving field force preparedness, deployment, and performance through innovative tools, training, and data-driven insights.